Hereditary nonpolyposis colorectal cancer family members' perceptions about the duty to inform and health professionals' role in disseminating genetic information

Genetic Testing

Volumn 9, Issue 3, 2005, Pages 261-268

  Pentz, Rebecca D ^a   Peterson, Susan K ^b   Watts, Beatty ^b   Vernon, Sally W ^c   Lynch, Patrick M ^b   Koehly, Laura M ^d   Gritz, Ellen R ^b  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COLORECTAL CANCER; CONFIDENTIALITY; DOCTOR PATIENT RELATION; FAMILY; FEMALE; GENE MUTATION; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; PARENTAL BEHAVIOR; PATIENT RIGHT;

EMPIRICAL APPROACH; GENETICS AND REPRODUCTION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; CONFIDENTIALITY; CROSS-SECTIONAL STUDIES; FAMILY; FEMALE; HEALTH PERSONNEL; HUMANS; INFORMATION DISSEMINATION; INTERVIEWS; MALE; MIDDLE AGED; PROFESSIONAL ROLE;

EID: 27144478922     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2005.9.261     Document Type: Article

References (54)

1. CFR § 160.510(j). Available 〈www.hhs.gov/ocr/regtext.html〉 Last accessed January 27, 2005.
2. Aarnio M, Sankila R, Pukkala E, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer, 81:214-218, 1999.
3. American Society of Clinical Oncology. Policy Statement Update: Genetic Testing for Cancer Susceptibility. J Clin Oncol, 21:2397-2406, 2003.
4. American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure. ASHG statement: Professional disclosure of familial genetic information. Am J Hum Genet, 62:474-483, 1998.
5. Ayme S, Macquart-Moulin G, Julian-Reynier C, et al. Diffusion of information about genetic risk within families. Neuromuscul Disord, 3:571-574, 1993.
6. Benkendorf JL, Reutenauer JE, Hughes CA, et al. Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility. Am J Med Genet, 73:296-304, 1997.
7. Blackburn M. HIPAA, heal thyself. Johns Hopkins Magazine, 56:50-55, 2004.
8. Burke W, Peterson G, Lynch P, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer: I. Hereditary nonpolyposis colon cancer. JAMA, 277:915-919, 1997.
9. Campbell CS, Lustig BA (eds). Duties to Others. The Netherlands, Kluwer Academic Publishers, 1994.
10. Claes E, Evers-Kiebooms G, Boogaerts A, et al. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet, 116A:11-19, 2003.
11. Council on Ethical and Judicial Affairs of the American Medical Association. Opinion E-2.131: Disclosure of Familial Risk in Genetic Testing. American Medical Association, Code of Medical Ethics: Current Opinion. Available 〈www.ama-assn.org/apps/pf_new/pf_ online?f_n=browse&doc=policyfiles/ HnE/E-2.131.HTM&&s_ t=&st_p=&nth=1&prev_pol=policyfiles/HnE/ E-1.02.HTM&nxt_ pol=policyfiles/HnE/E-2.01.HTM&〉 Last accessed online March 18, 2005.
12. D'Agincourt-Canning L. Experiences of genetic risk: Disclosure and the gendering of responsibility. Bioethics, 15:231-247, 2001.
13. Daly M, Itzen M, Costalas JW. The communication of BRCA 1 and BRACA2 test results to at risk relatives. Presented at Breast Cancer Symposium, 1997. San Antonio, TX. In Daly M, Farmer J, Harrop-Stein C, et al: Exploring family relationships in cancer risk counseling using the genogram. Cancer Epidemiol Biomarkers Prev, 8:393-398, 1999.
14. Doukas DJ, Berg JW. The family covenant and genetic testing. Am J Bioeth, 1:2-10, 2001.
15. Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet, 6:105-110, 1997.
16. Durfy SJ, Bowen DJ, McTiernan A, et al. Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev, 8:369-375, 1999.
17. Falk MJ, Dugan RB, O'Riordan M, et al. Medical geneticists' duty to warn at-risk relatives for genetic disease. Am J Med Genet, 120A:374-380, 2003.
18. Forrest K, Simpson SA, Wilson BJ, et al. To tell or not to tell: Barriers and facilitators in family communication about genetic risk. Clin Genet, 64:317-326, 2003.
19. Gollust SE, Apse K, Fuller BP, et al. Community involvement in developing policies for genetic testing: Assessing the interests and experiences of individuals affected by genetic conditions. Am J Pub Health, 95:35-11, 2005.
20. Green J, Richards M, Murton F, et al. Family communication and genetic counseling: The case of hereditary breast and ovarian cancer. J Genet Couns, 6:45-61, 1997.
21. Gritz ER, Peterson SK, Vernon SW, et al. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. Clin Oncol, 23:1902-1901, 2005.
22. Gritz ER, Vernon SW, Peterson SK, et al. Distress in the cancer patient and its association with genetic testing and counseling for hereditary non-polyposis colon cancer. Cancer Res Ther Control, 8:35-50, 1999.
23. Hallowell N, Foster C, Eeles R, et al. Balancing autonomy and responsibility: The ethics of generating and disclosing genetic information. J Med Ethics, 2:74-79, 2003.
24. Hughes C, Lerman C, Schwartz M, et al. All in the family: Evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet, 107:143-150, 2002.
25. Institute of Medicine Committee on Assessing Genetic Risks. Assessing Genetic Risks: Implications for Health and Social Policy. Washington, D.C.: National Academy Press, 1994.
26. Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology, 118:829-834, 2000.
27. Julian-Reynier C, Eisinger F, Vennin P, et al. Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet, 33:731-736, 1996.
28. Julian-Reynier C, Eisinger F, Chabal F, et al. Disclosure to the family of breast/ovarian cancer genetic test results: Patients' willingness and associated factors. Am J Med Genet, 94:13-18, 2000.
29. Kass NE, Sugarman J, Faden R, et al. Trust, the fragile foundation of contemporary biomedical research. Hastings Cent Rep, 26:25-29, 1996.
30. Kenen R, Ardern-Jones A, Eeles R. We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian cancer (HBOC). Psychooncology, 13:335-345, 2004.
31. Knoppers BM. Genetic information and the family: Are we our brother's keeper? Trends Biotechnol, 20:85-86, 2002.
32. Koehly LM, Peterson SK, Watts BG, et al. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiol Biomarkers Prev, 12:304-313, 2003.
33. Lehmann LS, Weeks JC, Klar N, et al. Disclosure of familial genetic information: Perceptions of the duty to inform. Am J Med, 109:705-711, 2000.
34. Lynch HT, de la Chapelle A. Genomic medicine: Herditary colorectal cancer. N Engl J Med, 48:919-932, 2003.
35. Mertz JF, Cho MK, Sandar P. Familial disclosure in defiance of non-consent. Am J Hum Genet, 63:898-899, 1998.
36. Miles M, Huberman A. Qualitative Data Analysis. Beverly Hills: Sage, 1994.
37. Offit K, Groeger E, Turner S, et al. The "duty to warn" a patient's family members about hereditary disease risks. JAMA, 292:1469-1473, 2004.
38. Parker M, Lucassen A. Concern for families and individuals in clinical genetics. J Med Ethics, 29:70-73, 2003.
39. Pate v. Threkel, 661 So. 2d 278, FL 1995.
40. Peterson SK, Watts BG, Koehly LM, et al. How families communication about HNPCC genetic testing: Findings from a qualitative study. Am J Med Genet, 119C:78-86, 2003.
41. Rothstein MA (ed). Genetic Secrets: A Policy Framework. New Haven: Yale University Press, 451-495 pp. 1997.
42. Safer v. Estate of Pack, 677 A.2d 1188, NJ Super A.D. 1996.
43. Salen DN, Parker SG. The adverse effects of HIPAA on patient care. N Engl J Med, 349:309, 2002.
44. Sawom KJ, Harrigan M. Measures of family functioning for research and practice. Sch Inq Nurs Pract, 8:5-142, 1994.
45. Sulmasy DP. Duty to warn about hereditary disease risks. JAMA, 293:676, 2005.
46. Vasen HF, Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch Syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology, 116:1453-1456, 1999.
47. Vasen HF, Stormorken A, Menko FH, et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol, 19:4074-4080, 2001.
48. Vernon SW, Gritz ER, Peterson SK, et al. Design and methodology of psychosocial aspects of genetic testing for hereditary colorectal cancer. Ann NY Acad Sci, 833:190-194, 1997.
49. Vernon SW, Gritz ER, Peterson SK, et al. Intention to learn the results of genetic testing for hereditary colon cancer. Cancer Epidemiol Biomarkers Prev, 8:353-360, 1999.
50. Wachbroit R. Rethinking medical confidentiality: The impact of genetics. Suffolk University Law Rev, 27:1391-1410, 1993.
51. Wachbroit R. Disowning Knowledge: Issues in Genetic Testing. Report from the Institute for Philosophy and Public Policy, Vol. 16. pp. 14-16, 1996.
52. Weijer C. Family duty is more important than rights. BMJ, 321:1466, 2000.
53. Wertz DC, Fletcher JC, Berg K. Review of Ethical Issues in Medical Genetics: Report of Consultants to WHO. Available 〈whqlibdoc. who.int/hq/2003/WHO_HGN_ETH_00.4.pdf〉 Last accessed online March 18, 2005.
54. Wilson BJ, Forrest K, van Teijlingen ER, et al. Family Communication about Generic Risk: The little that is know. Community Genet, 7:15-24, 2004.